Dorry Lidor Segev

Trends in GLP ‐1 Receptor Agonist Prescribing Without an Apparent FDA ‐Approved Indication

ABSTRACT Objective This study evaluated temporal trends and patient characteristics associated with glucagon‐like peptide‐1 (GLP‐1) receptor agonist prescribing among US adults without an apparent FDA‐approved indication. Methods This retrospective cohort study used Cosmos electr...

Early Changes in Kidney Transplantation following Implementation of the Increasing Organ Transplant Access Model

Background: The Increasing Organ Transplant Access (IOTA) model is a mandatory experimental payment model that aims to improve kidney transplant access using financial incentives and penalties for transplant centers randomized to model participation, based primarily on growth in...

Performance of the iBox Prognostication System in African American Kidney Transplant Recipients

Background: The iBox is a validated prognostication system that predicts long-term death-censored graft loss in kidney transplant recipients, but its performance in the specific population of African American recipients has not been fully studied. Methods: We conducted a multicen...